Factual end-of-day data for SUNPHARMA: price and volume, delivery percentage, 52-week position, indicator levels and intraday order flow. Refreshed after every NSE session.
Traded volume of 14,78,172 shares was close to the 20-day average.
SUNPHARMA touched a fresh 52-week high in this session.
SUNPHARMA's delivery share of 59.5% was in line with its 20-day average of 59.6%.
Intraday order-flow data from VolumeLens tick classification — the running difference between aggressive buying and selling volume. This dataset is not published by any other Indian platform.
Largest single sell-side trade: 3,007 shares at ₹1,934.07.
| Indicator | Reading (10 Jul 2026) |
|---|---|
| RSI (14) | 69.3 |
| 50-day EMA | ₹1,836.84 — close is above |
| 200-day EMA | ₹1,762.31 — close is above |
| SuperTrend (10, 3) | ₹1,832.07 — close is above the line |
Indicator values are computed from adjusted daily closes and describe where price sits relative to each level — they are statistics, not signals.
SUNPHARMA is a large-cap NSE stock in the Pharma sector (Drug Manufacturers - Specialty & Generic industry), with a market capitalisation of about ₹4,30,321 crore.
Footprint chart, DOM ladder, cumulative delta and volume profile — free to explore.